To study the effectiveness of tranexamic acid in reducing blood loss and postoperative complications in patients undergoing breast surgery
Not Applicable
- Conditions
- Health Condition 1: D249- Benign neoplasm of unspecified breastHealth Condition 2: C509- Malignant neoplasm of breast of unspecified site
- Registration Number
- CTRI/2024/04/065861
- Lead Sponsor
- Dr Hariharan R
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All females above 18 yrs of age undergoing breast surgery who consent to the study
Exclusion Criteria
Patients not giving consent
Patients with uncontrolled comorbidities
History of prior thromboembolic events
Patients with severe renal impairment
Patients with seizure disorder
Patients with retinal vein occlusion
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Effect of tranexamic acid in reducing postoperative bleeding <br/ ><br>2 effect of tranexamic acid in reducing postoperative pain <br/ ><br>3 effect of tranexamic acid in reducing other postoperative complicationsTimepoint: 4 weeks
- Secondary Outcome Measures
Name Time Method 1 Effect of tranexamic acid in reducing other postoperative complicationsTimepoint: 4 weeks